State Street’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-31,611
| Closed | -$6.86M | – | 4526 |
|
|
2021
Q1 | $6.86M | Buy |
31,611
+16,790
| +113% | +$3.16M | ﹤0.01% | 2917 |
|
|
2020
Q4 | $1.71M | Sell |
14,821
-4,354
| -23% | -$488K | ﹤0.01% | 3418 |
|
|
2020
Q3 | $1.87M | Sell |
19,175
-563
| -3% | -$64.8K | ﹤0.01% | 3226 |
|
|
2020
Q2 | $2.42M | Sell |
19,738
-2,117
| -10% | -$240K | ﹤0.01% | 3101 |
|
|
2020
Q1 | $1.91M | Buy |
21,855
+12,522
| +134% | +$1.33M | ﹤0.01% | 3084 |
|
|
2019
Q4 | $976K | Buy |
9,333
+639
| +7% | +$71.7K | ﹤0.01% | 3417 |
|
|
2019
Q3 | $1M | Sell |
8,694
-112
| -1% | -$17K | ﹤0.01% | 3397 |
|
|
2019
Q2 | $1.52M | Buy |
8,806
+447
| +5% | +$77.3K | ﹤0.01% | 3340 |
|
|
2019
Q1 | $1.41M | Sell |
8,359
-151
| -2% | -$22.5K | ﹤0.01% | 3265 |
|
|
2018
Q4 | $829K | Buy |
+8,510
| New | +$1.12M | ﹤0.01% | 3363 |
|
|
2017
Q4 | – | Sell |
-2,255
| Closed | -$229K | – | 3757 |
|
|
2017
Q3 | $229K | Buy |
2,255
+141
| +7% | +$15.1K | ﹤0.01% | 3587 |
|
|
2017
Q2 | $212K | Buy |
+2,114
| New | +$228K | ﹤0.01% | 3528 |
|
|
2016
Q1 | – | Sell |
-10,387
| Closed | -$721K | – | 3745 |
|
|
2015
Q4 | $721K | Buy |
+10,387
| New | +$846K | ﹤0.01% | 3276 |
|
Other funds holding GWPH
State Street's GWPH Position: Q2 2021 in Review
State Street sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 31,611 shares — an estimated $6.86M sold.
State Street first reported a position in GWPH in Q4 2015 and held it in 13 quarters. The position peaked at $6.86M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- State Street reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- State Street sold 31,611 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $6.86M.
- State Street first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 13 quarters.
- State Street's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6.86M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on State Street's 13F filing for Q2 2021, filed 16 Aug 2021.